Topic

HORIZON-EIC-2023-ACCELERATOROPEN-01

HORIZON-EIC-2023-ACCELERATOROPEN-01

Programme: Horizon Europe

126 projects · €299,709,635 total EU contribution (project-level) · 141 participating organizations · 23 countries with participants

Total EU funding

Sum of EC max contribution fields for distinct projects in this topic.

€299,709,635

Countries active

Participant organizations by country (headquarters in CORDIS).

Open calls

From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.

No open or forthcoming calls linked to this topic in the database yet.

Top organizations

By number of distinct projects in this topic.

Projects

Page 6 of 13

ProjectEU contribution

A breakthrough active immunotherapy for the treatment of osteoarthritis

Anti-IL-6 · 101145362

€2,499,999
Details

Optimization, demonstration of natural, biodegradable packaging from wood in desired shapes for various industries

RAIKU bio packaging · 101145196

€2,499,999
Details

World’s first diagnostic test that can detect all bacterial species in a single assay

Molecular Culture · 190132711

€2,499,999
Details

Additive Manufactured Automotive Antenna for Autonomous Driving

ACTIVATING · 101165759

€1,779,750
Details

Development of a natural therapeutic treatment for late-stage lung cancer patients

CB24 · 190166095

€2,499,999
Details

OMI AI ECG Model - application for more accurate heart attack diagnosis

OMI AI ECG Model · 101165721

€2,499,999
Details

A fully autonomous solar-powered lightweight weeding robot, using AI for plant recognition, precision contact and contactless weeding methods suited for hard soils, hilly terrains and arid climates.

RoboAIweeder · 101166300

€2,360,937
Details

THE NEXT STENT GENERATION: A FIRST-IN-CLASS REGENERATIVE NANOFIBER STENT TO RECONSTRUCT ARTERIES FROM THE INSIDE OUT

EX-STENT · 190170592

€2,500,000
Details

Panel Recycling and Integrated Solar Material

PRISM · 101145463

€2,084,977
Details

Innovative approach to an Individualised T-Cell Immunotherapy for cancer, using Personalised Tumour Trained Lymphocytes (pTTL) that is reliable, cost-effective, scalable and easy to implement

NEOpTTL · 190185439

€2,500,000
Details